Andrew N Schiff Aclaris Therapeutics, Inc. (ACRS) insider trading activity

ACRS Quotes by TradingView

Andrew N Schiff is of Aclaris Therapeutics, Inc.. Currently has a direct ownership of 13,960 shares of ACRS, which is worth approximately $23,452. The most recent transaction as insider was on Jun 06, 2025, when has been sold 4,793 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14K
52.29% 3M change
52.29% 12M change
Total Value Held $23,452

ANDREW N SCHIFF Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2025
BUY
Exercise of conversion of derivative security
-
4,793 Added 25.56%
13,960 Common Stock
Jun 01 2024
BUY
Exercise of conversion of derivative security
-
4,660 Added 33.7%
9,167 Common Stock
Jun 02 2023
BUY
Exercise of conversion of derivative security
-
4,507 Added 50.0%
4,507 Common Stock
Jun 17 2022
SELL
Open market or private sale
$296,214 $15.14 p/Share
19,565 Reduced 100.0%
0 Common Stock
Jun 03 2022
BUY
Exercise of conversion of derivative security
-
3,356 Added 14.64%
19,565 Common Stock

Also insider at

GLUE
Monte Rosa Therapeutics, Inc. Healthcare
ANS

Andrew N Schiff

Wayne, PA

Track Institutional and Insider Activities on ACRS

Follow Aclaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRS shares.

Notify only if

Insider Trading

Get notified when an Aclaris Therapeutics, Inc. insider buys or sells ACRS shares.

Notify only if

News

Receive news related to Aclaris Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACRS